N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study

Schizophr Res. 2019 Jun:208:479-480. doi: 10.1016/j.schres.2019.01.036. Epub 2019 Jan 31.

Authors

Yvonne S Yang¹, Michael C Davis², Jonathan K Wynn³, Gerhard Hellemann⁴, Michael F Green³, Stephen R Marder³

Affiliations

¹ VISN22 MIRECC Greater Los Angeles Veterans Affairs Healthcare System, United States of America. Electronic address: ysyang@mednet.ucla.edu.
² Division of Psychiatry Products, US Food and Drug Administration.
³ VISN22 MIRECC Greater Los Angeles Veterans Affairs Healthcare System, United States of America.
⁴ Biostatistics Core, Semel Institute for Neuroscience and Human Behavior, UCLA.

PMID: 30712814
DOI: 10.1016/j.schres.2019.01.036

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Acetylcysteine / therapeutic use*
Adult
Cognition*
Double-Blind Method
Electroencephalography
Electroencephalography Phase Synchronization
Evoked Potentials, Auditory / physiology*
Female
Free Radical Scavengers / therapeutic use*
Humans
Male
Middle Aged
Pilot Projects
Schizophrenia / drug therapy*
Schizophrenia / physiopathology
Schizophrenic Psychology*

Substances

Free Radical Scavengers
Acetylcysteine